A Cleveland, Ohio medical device manufacturer drew a Form 483 after the FDA’s January inspection found the firm’s procedures were inadequate.

The investigator observed that the firm’s procedures for receiving, reviewing and evaluating complaints were not fully developed.

The firm’s complaint forms did not document an assessment of the MDR, the contact information of the complainant or the firm’s reply to the complainant.